MAR
50
6
COP
45
-2
AEE
41
-2
CRM
55
-2
ALL
48
3
MPC
41
2
WMT
75
13
WU
48
-2
PH
67
-4
MMC
70
3
PEP
54
3
MRO
40
-2
HST
52
4
ZTS
65
2
M
50
2
RCL
66
4
FCX
54
-16
TEL
86
-2
IR
80
-5
CVX
23
-2
MAR
50
6
COP
45
-2
AEE
41
-2
CRM
55
-2
ALL
48
3
MPC
41
2
WMT
75
13
WU
48
-2
PH
67
-4
MMC
70
3
PEP
54
3
MRO
40
-2
HST
52
4
ZTS
65
2
M
50
2
RCL
66
4
FCX
54
-16
TEL
86
-2
IR
80
-5
CVX
23
-2
Financhill
Back

American Oncology Network 10K Form

Sell
6

AONC
American Oncology Network

Last Price:
3.00
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AONC News And Ratings

See the #1 stock for the next 7 days that we like better than AONC

AONC Financial Statistics

Sales & Book Value

Annual Sales: $1.28B
Cash Flow: $41.01M
Price / Cash Flow: 1.22
Annual Sales: $-15.79
Price / Book: 0

Profitability

EPS (TTM): -2.58000
Net Income (TTM): $-13.38M
Gross Margin: $82.8M
Return on Equity: -18.99%
Return on Assets: -3.53%

American Oncology Network Earnings Forecast

Key American Oncology Network Financial Ratios

  • The Gross Profit Margin over the past 4 years for AONC is 6.47%.
  • The Selling, General & Administrative Expenses for AONC have been equal to 7.87% of Gross Profit Margin.
  • The Interest Expense is -115.79% of Operating Income.
  • The Net Earning history of AONC is -0.43% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 1 years.

American Oncology Network Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: AONC
Website: aoncology.com

Debt

Debt-to-Equity Ratio: -0.79
Current Ratio: 1.39
Quick Ratio: 1.17

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AONC Technical Analysis vs Fundamental Analysis

Sell
6
American Oncology Network (AONC) is a Sell

Is American Oncology Network a Buy or a Sell?